DiscoverThe Chain: Protein Engineering PodcastEpisode 65- Tariq Ghayur on the Renaissance of Bispecifics and ADCs, AI, and More
Episode 65- Tariq Ghayur on the Renaissance of Bispecifics and ADCs, AI, and More

Episode 65- Tariq Ghayur on the Renaissance of Bispecifics and ADCs, AI, and More

Update: 2024-09-10
Share

Description

September 10, 2024 | In this episode of The Chain, host Nimish Gera speaks with Tariq Ghayur, of Tariq Ghayur Consulting, LLC and Entrepreneur in Residence, FairJourney Biologics (and a fellow host of the podcast), about the current renaissance of bispecifics and ADCs, the impact of AI in pharmaceuticals, and what to watch out for in the biopharma space in the next few years. Ghayur also shares his journey from BASF Pharma to AbbVie, what it was like when the industry shifted its focus from small molecules to biologics, and the major differences between doing a postdoc in academia versus in the industry. 

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 65- Tariq Ghayur on the Renaissance of Bispecifics and ADCs, AI, and More

Episode 65- Tariq Ghayur on the Renaissance of Bispecifics and ADCs, AI, and More

Cambridge Healthtech Institute